Therapeutic compounds for HIV virus infection
US11787825B2 · kind B2 · utility
4Cited by
50References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2022 |
| Grant date | Oct 17, 2023 |
| Priority date | — |
| Expiry date | Dec 2, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65583
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of a Retroviridae infection, including an HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.